GAL001-006

screened

GAL-001: Adaptive Phase II in Refractory Melanoma · Phase II
St. Brigid University Hospital · Dr. C. Nolan

AEs
0
Serious
0
Dropout signal

Adverse events

No adverse events recorded.

Data queries

No data queries.